132 related articles for article (PubMed ID: 2440016)
41. Enhanced transfer of experimental allergic encephalomyelitis with Lewis rat lymph node cells.
Richert JR; Kies MW; Alvord EC
J Neuroimmunol; 1981 Jun; 1(2):195-203. PubMed ID: 6175659
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy.
Urban JL; Horvath SJ; Hood L
Cell; 1989 Oct; 59(2):257-71. PubMed ID: 2478292
[TBL] [Abstract][Full Text] [Related]
43. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice.
Mokhtarian F; McFarlin DE; Raine CS
Nature; 1984 May 24-30; 309(5966):356-8. PubMed ID: 6203039
[TBL] [Abstract][Full Text] [Related]
44. Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis.
Jiang H; Curran S; Ruiz-Vazquez E; Liang B; Winchester R; Chess L
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8378-83. PubMed ID: 12824465
[TBL] [Abstract][Full Text] [Related]
45. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis.
Offner H; Jones R; Vandenbark AA
Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830
[No Abstract] [Full Text] [Related]
46. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
Tabi Z; McCombe PA; Pender MP
Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
[TBL] [Abstract][Full Text] [Related]
47. Autoimmune thyroiditis and targeted anti-T cell immunotherapy in man.
Dayan CM; Feldmann M; Rapoport B; Londei M
Autoimmunity; 1992; 11(3):189-98. PubMed ID: 1373961
[No Abstract] [Full Text] [Related]
48. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
49. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.
Clayton JP; Gammon GM; Ando DG; Kono DH; Hood L; Sercarz EE
J Exp Med; 1989 May; 169(5):1681-91. PubMed ID: 2469764
[TBL] [Abstract][Full Text] [Related]
50. The autoreactive T cell population in experimental allergic encephalomyelitis: T cell receptor beta-chain rearrangements.
Happ MP; Kiraly AS; Offner H; Vandenbark A; Heber-Katz E
J Neuroimmunol; 1988 Sep; 19(3):191-204. PubMed ID: 2457602
[TBL] [Abstract][Full Text] [Related]
51. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
Vandenbark AA; Hashim G; Offner H
Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
[No Abstract] [Full Text] [Related]
52. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.
Zamvil SS; Mitchell DJ; Powell MB; Sakai K; Rothbard JB; Steinman L
J Exp Med; 1988 Sep; 168(3):1181-6. PubMed ID: 2459291
[TBL] [Abstract][Full Text] [Related]
53. Recovery mechanisms from experimental allergic encephalomyelitis in rats: analyses by using encephalitogenic T cell line.
Namikawa T; Satoh J; Yamamura T; Sakai K; Kunishita T; Tabira T
Int Arch Allergy Appl Immunol; 1987; 83(4):366-70. PubMed ID: 2440815
[TBL] [Abstract][Full Text] [Related]
54. Fine specificity of myelin basic protein reactive T-cells: implications for T-cell receptor antagonism.
Anderton SM; Manickasingham SP; Wraith DC
Biochem Soc Trans; 1997 May; 25(2):659-61. PubMed ID: 9191175
[No Abstract] [Full Text] [Related]
55. Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active disease in the donor.
Cross AH; Raine CS
J Neuroimmunol; 1990 Jun; 28(1):27-37. PubMed ID: 1692846
[TBL] [Abstract][Full Text] [Related]
56. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10.
Stohlman SA; Pei L; Cua DJ; Li Z; Hinton DR
J Immunol; 1999 Dec; 163(11):6338-44. PubMed ID: 10570329
[TBL] [Abstract][Full Text] [Related]
57. Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice.
Sakai K; Namikawa T; Kunishita T; Yamanouchi K; Tabira T
J Immunol; 1986 Sep; 137(5):1527-31. PubMed ID: 3489035
[TBL] [Abstract][Full Text] [Related]
58. Acute experimental allergic encephalomyelitis. Myelin basic protein-reactive T cells in the circulation and in meningeal infiltrates.
Traugott U; Raine CS
J Neurol Sci; 1979 Aug; 42(3):331-6. PubMed ID: 92528
[TBL] [Abstract][Full Text] [Related]
59. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis.
Ufret-Vincenty RL; Quigley L; Tresser N; Pak SH; Gado A; Hausmann S; Wucherpfennig KW; Brocke S
J Exp Med; 1998 Nov; 188(9):1725-38. PubMed ID: 9802984
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
